4//SEC Filing
Johnson Kevin C 4
Accession 0001077183-19-000154
CIK 0001077183other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 5:41 PM ET
Size
12.6 KB
Accession
0001077183-19-000154
Insider Transaction Report
Form 4
Johnson Kevin C
Director
Transactions
- Sale
Common Stock
2019-08-26$24.74/sh−11,800$291,932→ 28,285 total - Sale
Common Stock
2019-08-23$25.60/sh−41,200$1,054,720→ 40,085 total
Holdings
- 8,333
Stock Option (Right to Buy)
Exercise: $9.11From: 2017-07-28Exp: 2021-07-28→ Common Stock (8,333 underlying) - 3,017
Stock Option (Right to Buy)
Exercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying) - 6,667
Stock Option (Right to Buy)
Exercise: $4.78From: 2016-05-06Exp: 2020-05-06→ Common Stock (6,667 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $7.27From: 2018-05-25Exp: 2022-05-25→ Common Stock (10,000 underlying) - 4,269
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying)
Footnotes (3)
- [F1]On May 6, 2015 Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F2]On July 28, 2016, Mr. Johnson was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F3]On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001353436
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 5:41 PM ET
- Size
- 12.6 KB